Aminolinx
Natural health product licensed in Canada
- Licence holder
- Pro Supps USA, LLC
- NPN or DIN-HM
- 80046764
- Status
- Active licence
- Licence date
- 29 November 2013
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Alpha-cétoglutarate de L-arginine | 1 g | Not calculated |
| L-phénylalanine | 500 mg | Not calculated |
| L-Valine | 1,250 mg | Not calculated |
| Magnésium Source : Aspartate de magnésium | 60 mg | Not calculated |
| L-Histidine Source : Chlorhydrate de L-histidine | 202 mg | Not calculated |
Non-medicinal ingredients
Saveur d'écorce de Merisier, Rouge FD&C N° 40, Acide l-tartrique, Saveur de punch aux fruits, Saveur de framboise, Acide citrique, Saveur de melon d'eau, Lécithine, Sucralose, Saveur de lime
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Mesures | 1 day |
Uses authorised in Canada
L-leucine, L-isoleucine, and L-valine are essential amino acids involved in protein synthesis. Magnesium helps maintain proper muscle function. Magnesium, Vitamin B6 and Vitamin B12 help the body to metabolize carbohydrates, fats, and proteins. Magnesium and Vitamin B6 help in tissue formation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have Parkinson's disease, tardive dyskinesia, or are following a low protein diet. Consult a health care practitioner prior to use if you have liver or kidney disease.
- Contre-indications
Do not use if you are pregnant, breastfeeding, or taking Levodopa, a medication used to treat Parkinson's disease. Not suitable for consumption by persons allergic to wheat or gluten.
- Effets indésirables connus
May cause headache, in which case discontinue use. May cause a flushing, tingling and/or prickling sensation of the skin, in which case reduce the dose.
Source
Official Health Canada record, licence 80046764
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.